These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 34360727)
21. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Alam NA; Rowan AJ; Wortham NC; Pollard PJ; Mitchell M; Tyrer JP; Barclay E; Calonje E; Manek S; Adams SJ; Bowers PW; Burrows NP; Charles-Holmes R; Cook LJ; Daly BM; Ford GP; Fuller LC; Hadfield-Jones SE; Hardwick N; Highet AS; Keefe M; MacDonald-Hull SP; Potts ED; Crone M; Wilkinson S; Camacho-Martinez F; Jablonska S; Ratnavel R; MacDonald A; Mann RJ; Grice K; Guillet G; Lewis-Jones MS; McGrath H; Seukeran DC; Morrison PJ; Fleming S; Rahman S; Kelsell D; Leigh I; Olpin S; Tomlinson IP Hum Mol Genet; 2003 Jun; 12(11):1241-52. PubMed ID: 12761039 [TBL] [Abstract][Full Text] [Related]
22. Fumarate Hydratase is a Novel Gene for Familial Non-Medullary Thyroid Cancer. Alzahrani AS; Alswailem M; Alghamdi B; Al-Hindi H J Clin Endocrinol Metab; 2022 Aug; 107(9):2539-2544. PubMed ID: 35751867 [TBL] [Abstract][Full Text] [Related]
23. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL]. Plevová P; Hladíková A; Tesařová M Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208 [TBL] [Abstract][Full Text] [Related]
24. Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report. Iribe Y; Furuya M; Shibata Y; Yasui M; Funahashi M; Ota J; Iwashita H; Nagashima Y; Hasumi H; Hayashi N; Makiyama K; Kondo K; Tanaka R; Yao M; Nakaigawa N Fam Cancer; 2021 Jan; 20(1):75-80. PubMed ID: 32666341 [TBL] [Abstract][Full Text] [Related]
25. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287 [TBL] [Abstract][Full Text] [Related]
27. Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report. Kamai T; Abe H; Arai K; Murakami S; Sakamoto S; Kaji Y; Yoshida KI BMC Cancer; 2016 Mar; 16():232. PubMed ID: 26983443 [TBL] [Abstract][Full Text] [Related]
28. Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation. da Cunha IW; da Costa WH; Morini MA; Bezerra SM; Carraro DM; Torrezan GT; Formiga MNC; Guimaraes GC; Zequi SC; Soares FA Virchows Arch; 2018 Dec; 473(6):775-779. PubMed ID: 30171332 [TBL] [Abstract][Full Text] [Related]
29. Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing. Lu E; Hatchell KE; Nielsen SM; Esplin ED; Ouyang K; Nykamp K; Zavoshi S; Li S; Zhang L; Wilde BR; Christofk HR; Boutros PC; Shuch B Cancer; 2022 Feb; 128(4):675-684. PubMed ID: 34724198 [TBL] [Abstract][Full Text] [Related]
31. Multiple cutaneous leiomyomas leading to discovery of novel splice mutation in the fumarate hydratase gene associated with HLRCC. Tan RYP; Walsh M; Howard A; Winship I Australas J Dermatol; 2017 Nov; 58(4):e246-e248. PubMed ID: 28266706 [TBL] [Abstract][Full Text] [Related]
32. [A special uterine leiomyoma]. Brunet A; Verkarre V; Le Frère Belda MA Ann Pathol; 2020 Apr; 40(2):180-184. PubMed ID: 32192807 [TBL] [Abstract][Full Text] [Related]
33. Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report. Chan MMY; Barnicoat A; Mumtaz F; Aitchison M; Side L; Brittain H; Bates AWH; Gale DP BMC Med Genet; 2017 Jul; 18(1):79. PubMed ID: 28747166 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome). Buelow B; Cohen J; Nagymanyoki Z; Frizzell N; Joseph NM; McCalmont T; Garg K Am J Surg Pathol; 2016 Jul; 40(7):982-8. PubMed ID: 26945337 [TBL] [Abstract][Full Text] [Related]
35. Fumarate hydratase immunohistochemical staining may help to identify patients with multiple cutaneous and uterine leiomyomatosis (MCUL) and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome. Llamas-Velasco M; Requena L; Kutzner H; Schärer L; Rütten A; Hantschke M; Paredes BE; Mentzel T J Cutan Pathol; 2014 Nov; 41(11):859-65. PubMed ID: 25292446 [TBL] [Abstract][Full Text] [Related]
36. Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology. Uimari O; Ahtikoski A; Kämpjärvi K; Butzow R; Järvelä IY; Ryynänen M; Aaltonen LA; Vahteristo P; Kuismin O Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2066-2075. PubMed ID: 34480341 [TBL] [Abstract][Full Text] [Related]
37. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer. Ahvenainen T; Lehtonen HJ; Lehtonen R; Vahteristo P; Aittomäki K; Baynam G; Dommering C; Eng C; Gruber SB; Grönberg H; Harvima R; Herva R; Hietala M; Kujala M; Kääriäinen H; Sunde L; Vierimaa O; Pollard PJ; Tomlinson IP; Björck E; Aaltonen LA; Launonen V Cancer Genet Cytogenet; 2008 Jun; 183(2):83-8. PubMed ID: 18503824 [TBL] [Abstract][Full Text] [Related]
38. Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings. Harrison WJ; Andrici J; Maclean F; Madadi-Ghahan R; Farzin M; Sioson L; Toon CW; Clarkson A; Watson N; Pickett J; Field M; Crook A; Tucker K; Goodwin A; Anderson L; Srinivasan B; Grossmann P; Martinek P; Ondič O; Hes O; Trpkov K; Clifton-Bligh RJ; Dwight T; Gill AJ Am J Surg Pathol; 2016 May; 40(5):599-607. PubMed ID: 26574848 [TBL] [Abstract][Full Text] [Related]
39. Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer. Crooks DR; Cawthon GM; Fitzsimmons CM; Perez M; Ricketts CJ; Vocke CD; Yang Y; Middelton L; Nielsen D; Schmidt LS; Tandon M; Merino MJ; Ball MW; Meier JL; Batista PJ; Linehan WM Hum Mol Genet; 2023 Nov; 32(22):3135-3145. PubMed ID: 37561409 [TBL] [Abstract][Full Text] [Related]
40. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma. Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]